Showing 1 - 20 results of 34 for search 'Vivek Subbiah', query time: 0.03s
Refine Results
-
1
-
2
COVID-19 Pandemic and Cancer Clinical Trial Pandemonium: Finding the Silver Lining by Aakash Desai, Vivek Subbiah
Published 2021-05-01
Article -
3
Precision oncology with selective RET inhibitor selpercatinib in -rearranged cancers by Mohamed A. Gouda, Vivek Subbiah
Published 2023-06-01
Article -
4
-
5
An Assessment of Early Response to Targeted Therapy via Molecular Imaging: A Pilot Study of 3′-deoxy-3′[(18)F]-Fluorothymidine Positron Emission Tomography 18F-FLT PET/CT in Prosta... by Kalevi Kairemo, Gregory C. Ravizzini, Homer A. Macapinlac, Vivek Subbiah
Published 2017-04-01
Article -
6
For what it’s worth: the complex area of medicine value assessment by Sreeram V Ramagopalan, Catrin Treharne, Jonathan Pearson-Stuttard, Vivek Subbiah
Published 2023-01-01Article -
7
-
8
The L730V/I RET roof mutations display different activities toward pralsetinib and selpercatinib by Tao Shen, Xueqing Hu, Xuan Liu, Vivek Subbiah, Blaine H. M. Mooers, Jie Wu
Published 2021-06-01
Article -
9
Drugging KRAS: current perspectives and state-of-art review by Kaushal Parikh, Giuseppe Banna, Stephen V. Liu, Alex Friedlaender, Aakash Desai, Vivek Subbiah, Alfredo Addeo
Published 2022-10-01
Article -
10
-
11
Cancer Genetics and Therapeutic Opportunities in Urologic Practice by Jacob J. Adashek, Alex Leonard, Jason Roszik, Arjun K. Menta, Giannicola Genovese, Vivek Subbiah, Pavlos Msaouel
Published 2020-03-01
Article -
12
-
13
-
14
Challenges in diagnosis and biomarker testing for RET-altered lung and thyroid cancer care: an international mixed-method study by Patrice Lazure, Anthony Sireci, Vivek Subbiah, Suzanne Murray, Christian Grohé, Steven I. Sherman, Elizabeth Kelly, Patrick Bubach, Sophie Péloquin
Published 2023-06-01
Article -
15
-
16
Unique Aberrations in Intimal Sarcoma Identified by Next-Generation Sequencing as Potential Therapy Targets by Jason Roszik, Abir Khan, Anthony P. Conley, J. Andrew Livingston, Roman Groisberg, Vinod Ravi, Roberto Carmagnani Pestana, Shiraj Sen, Vivek Subbiah
Published 2019-08-01
Article -
17
Dosimetry of a Novel <sup>111</sup>Indium-Labeled Anti-P-Cadherin Monoclonal Antibody (FF-21101) in Non-Human Primates by Gregory Ravizzini, William Erwin, Louis De Palatis, Lucia Martiniova, Vivek Subbiah, Vincenzo Paolillo, Jennifer Mitchell, Asa P. McCoy, Jose Gonzalez, Osama Mawlawi
Published 2023-09-01
Article -
18
Emergence of mTOR mutation as an acquired resistance mechanism to AKT inhibition, and subsequent response to mTORC1/2 inhibition by Niamh Coleman, Vivek Subbiah, Shubham Pant, Keyur Patel, Sinchita Roy-Chowdhuri, Sireesha Yedururi, Amber Johnson, Timothy A. Yap, Jordi Rodon, Kenna Shaw, Funda Meric-Bernstam
Published 2021-12-01
Article -
19
-
20
Phase II Clinical Trial of Pembrolizumab in Patients with Progressive Metastatic Pheochromocytomas and Paragangliomas by Camilo Jimenez, Vivek Subbiah, Bettzy Stephen, Junsheng Ma, Denai Milton, Mingxuan Xu, Abdualrazzak Zarifa, Fechukwu Omolara Akhmedzhanov, Apostolia Tsimberidou, Mouhammed Amir Habra, Jordi Rodon Anhert, Siqing Fu, Aung Naing
Published 2020-08-01
Article